#therapeutics

U.S. Tariffs Threaten Pharma Supply Chains and Valuations

U.S. trade policy uncertainty poses material risks to specialized pharmaceutical manufacturers like Intensity Therapeutics, which rely on globally sourced inputs and components. Tariff escalation—whet